Jazz Pharmaceuticals
JAZZ
#2282
Rank
โ‚ฌ5.50 B
Marketcap
90,60ย โ‚ฌ
Share price
3.03%
Change (1 day)
-11.30%
Change (1 year)

Earnings for Jazz Pharmaceuticals (JAZZ)

Earnings in 2024 (TTM): โ‚ฌ0.43 Billion

According to Jazz Pharmaceuticals's latest financial reports the company's current earnings are โ‚ฌ4.06 Billion. , an increase over its 2023 earnings that were of โ‚ฌ0.26 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Jazz Pharmaceuticals from 2005 to 2024

Annual earnings

Year Earnings Change
2024 โ‚ฌ0.41 B57.87%
2023 โ‚ฌ0.26 B-179.92%
2022 -โ‚ฌ0.33 Billion230.37%
2021 -โ‚ฌ98.9 Million-141.02%
2020 โ‚ฌ0.24 B-39.45%
2019 โ‚ฌ0.39 B-14.2%
2018 โ‚ฌ0.46 B20.03%
2017 โ‚ฌ0.38 B-17.15%
2016 โ‚ฌ0.46 B22.14%
2015 โ‚ฌ0.38 B187.64%
2014 โ‚ฌ0.13 B-50.79%
2013 โ‚ฌ0.26 B73.63%
2012 โ‚ฌ0.15 B41.69%
2011 โ‚ฌ0.10 B116.61%
2010 โ‚ฌ50.64 M262.77%
2009 โ‚ฌ13.96 M-111.33%
2008 -โ‚ฌ0.13 Billion1.31%
2007 -โ‚ฌ0.13 Billion77.8%
2006 -โ‚ฌ68.41 Million36.59%
2005 -โ‚ฌ50.09 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-โ‚ฌ2.1 Billion-608.54%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
โ‚ฌ1.83 B 345.78%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ11.95 B 2,799.96%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
-โ‚ฌ0.25 Billion-159.96%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel